Business
Ubika Research initiates coverage on Medworxx Solutions Inc.
Ubika Research initiates coverage on Medworxx Solutions Inc.
About this update from Regenx Tech Corp
[{"type":"text","content":"\nUbika Research initiates coverage on Medworxx Solutions Inc.\n\n\n Oct. 7, 2009 (Baystreet.ca) -- TORONTO, Canada - Ubika Research has initiated coverage on Medworxx Solutions Inc. (TSXV: MWX) in a report, \"Improving efficiency in health care - a technology play” (dated Oct 7, 2009). Medworxx Solutions through its patient flow, learning and compliance products helps to improve patient care efficiency and knowledge management within hospitals and other health care organizations. \nUbika Research believes that Medworxx Solutions could leverage its strong customer base of close to 300 hospitals in both Canada &US as a spring board to achieve top line revenue growth and achieve margin expansion with its recurring revenue model. Medworxx Solutions is rated “Speculative Buy” by Ubika Research, with a 12-month target of C$ 0.30. \nDownload the free report at http://www.ubikaresearch.com/report/medworxx.aspx \nAbout Medworxx Solutions Inc.\nMedworxx Solutions Inc. (MWX-TSX-V) provides software for patient flow, compliance and education in the healthcare market. Hospitals across North America use its solutions to communicate, aggregate, and analyze knowledge in order to support decision making and regulatory compliance, reduce costs and improve operational efficiency. Based in Toronto, Canada, its marketing footprint spans nine provinces in Canada and 17 states in the U.S. \nAbout Ubika Research\nUbika offers research, analytics and communications solutions to various areas of the financial services industry. We offer solutions that enhance revenue generation capabilities and provide clear competitive advantages. For more information visit www.ubikaresearch.com \n \nDisclosure\nExcept for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.Ubika Research, a division of Ubika Corporation, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice. For full disclo...